N-{4-[4-(4'-Chloro-biphenyl-2-ylmethyl)-piperazin-1-yl]-benzoyl}-C-[3-(2-morpholin-4-yl-ethoxy)-adamantan-1-yl]-methanesulfonamide

ID: ALA2089295

Chembl Id: CHEMBL2089295

PubChem CID: 70682877

Max Phase: Preclinical

Molecular Formula: C41H51ClN4O5S

Molecular Weight: 747.40

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NS(=O)(=O)CC12CC3CC(C1)CC(OCCN1CCOCC1)(C3)C2)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1

Standard InChI:  InChI=1S/C41H51ClN4O5S/c42-36-9-5-33(6-10-36)38-4-2-1-3-35(38)28-45-13-15-46(16-14-45)37-11-7-34(8-12-37)39(47)43-52(48,49)30-40-24-31-23-32(25-40)27-41(26-31,29-40)51-22-19-44-17-20-50-21-18-44/h1-12,31-32H,13-30H2,(H,43,47)

Standard InChI Key:  JUSSDUSHYLMUFB-UHFFFAOYSA-N

Associated Targets(Human)

BCL2 Tclin Apoptosis regulator Bcl-2/Bcl-2 homologous antagonist/killer (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 747.40Molecular Weight (Monoisotopic): 746.3269AlogP: 6.08#Rotatable Bonds: 12
Polar Surface Area: 91.42Molecular Species: ACIDHBA: 8HBD: 1
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.07CX Basic pKa: 8.36CX LogP: 4.75CX LogD: 4.59
Aromatic Rings: 3Heavy Atoms: 52QED Weighted: 0.24Np Likeness Score: -1.08

References

1. Yusuff N, Doré M, Joud C, Visser M, Springer C, Xie X, Herlihy K, Porter D, Touré BB..  (2012)  Lipophilic Isosteres of a π-π Stacking Interaction: New Inhibitors of the Bcl-2-Bak Protein-Protein Interaction.,  (7): [PMID:24900514] [10.1021/ml300095a]

Source